Source: U.S. Department of the Treasury – OFAC

HyperBranch Medical Technology, Inc. (“HyperBranch”) of Durham, North Carolina, has agreed to pay $107,691.30 to settle potential civil liability for apparent violations of the Iranian Transactions and Sanctions Regulations, 31 C.F.R. part 560 (the “Regulations”).

Specifically: (1) on or about April 15, 2011, HyperBranch appears to have violated § 560.204 of the Regulations when it exported 1,600 units of Adherus Dural Sealant, 2,000 units of Adherus Spinal Sealant, 20 units of Adherus Dural Sealant samples, and approximately 60 units of Adherus Spinal Sealant samples to its United Arab Emirates distributer with knowledge or reason to know that the goods were ultimately destined for Iran; and (2) on or about May 27, 2011, HyperBranch appears to have violated § 560.204 of the Regulations when it exported 400 units of Adherus Dural Sealant to its United Arab Emirates distributer with knowledge or reason to know…

Read More >>

926 View

Leave a Comment